Read + Share
Amedeo Smart
Independent Medical Education
de Weerd AE, Fatly ZA, Boer-Verschragen M, Kal-van Gestel JA, et al. Tacrolimus Monotherapy is Safe in Immunologically Low-Risk Kidney Transplant Recipients: A Randomized-Controlled Pilot Study. Transpl Int 2022;35:10839.PMID: 36353052
Email
LinkedIn
Facebook
Twitter
Privacy Policy